AL-38022A

AL-38022A
Identifiers
IUPAC name
  • (S)-2-(8,9-Dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17N3O
Molar mass231.299 g·mol−1
3D model (JSmol)
Melting point106 to 107 °C (223 to 225 °F)
SMILES
  • c13CCCOc3ccc(cn2)c1n2CC(C)N
InChI
  • InChI=1S/C13H17N3O/c1-9(14)8-16-13-10(7-15-16)4-5-12-11(13)3-2-6-17-12/h4-5,7,9H,2-3,6,8,14H2,1H3/t9-/m0/s1 checkY
  • Key:FJRIVFVALIEIOY-VIFPVBQESA-N checkY
 ☒NcheckY (what is this?)  (verify)

AL-38022A is an indazolethylamine derivative drug which is one of a range of similar drugs developed for scientific research and with some possible clinical applications such as in the treatment of glaucoma.[1] It acts as a potent and selective agonist for the 5-HT2 family of serotonin receptors, with highest binding affinity for the 5-HT2C subtype and around four times less affinity for 5-HT2A and 5-HT2B. In drug discrimination tests on animals, it fully substituted for both DOM and 5-MeO-DMT.[2]

See also

References

  1. Chen HH, May JA, Severns BS. Pyranoindazoles and their use for the treatment of glaucoma. US 6881749
  2. May JA, Sharif NA, Chen HH, Liao JC, Kelly CR, Glennon RA, et al. (January 2009). "Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine]". Pharmacology, Biochemistry, and Behavior. 91 (3): 307–14. doi:10.1016/j.pbb.2008.07.015. PMC 3763814. PMID 18718483.